E
Biodesix, Inc. BDSX
$0.4266 -$0.0198-4.44% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 25.70% 35.76% 45.30% 48.92% 46.25%
Total Other Revenue -- -- -- -- --
Total Revenue 25.70% 35.76% 45.30% 48.92% 46.25%
Cost of Revenue 19.04% 23.70% 19.70% 12.85% 2.32%
Gross Profit 27.63% 39.51% 54.53% 63.93% 66.97%
SG&A Expenses 15.47% 16.52% 19.39% 12.87% 6.80%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 17.45% 17.73% 16.81% 8.39% 0.66%
Operating Income -2.27% 9.83% 17.04% 28.51% 36.00%
Income Before Tax 7.71% 14.11% 17.67% 30.82% 32.66%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 7.71% 14.11% 17.67% 30.82% 32.66%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 7.71% 14.11% 17.67% 30.82% 32.66%
EBIT -2.27% 9.83% 17.04% 28.51% 36.00%
EBITDA 1.66% 16.78% 24.97% 35.11% 41.04%
EPS Basic 39.24% 47.46% 45.67% 56.19% 58.09%
Normalized Basic EPS 39.12% 48.06% 46.24% 52.97% 55.56%
EPS Diluted 39.24% 47.46% 45.67% 56.19% 58.09%
Normalized Diluted EPS 39.12% 48.06% 46.24% 52.97% 55.56%
Average Basic Shares Outstanding 47.87% 62.96% 57.55% 57.58% 55.73%
Average Diluted Shares Outstanding 47.87% 62.96% 57.55% 57.58% 55.73%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --